BioSpace News Archive

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received preliminary approval for a tax credit from the New Jersey Economic Development Authority

We are happy to share that none of clinical trials performed by Smooth Drug Development were paused or cancelled regardless the challenges encompassing a range of clinical trials activities.

Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that its clean sweetener consumer brand, Purecane™, has been named to Fast Company’s World’s Most Innovative Companies list for 2021.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced that the company initiated a second pre-clinical study in animals for potential treatment of liver fibrosis

Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery division today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions.

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, and Solar Therapeutics (Solar), America’s only energy-independent cannabis dispensary, announced today that the companies’ collaborative LED implementation yielded more than $1 million in total rebates from National Grid, Solar’s local utility provider.

Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.”

The demand within the global market for hospital asset tracking and inventory management systems has been rising on account of commercialisation of the healthcare industry.

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems.

The array of approved deep brain stimulation devices worldwide has expanded strikingly to treat hard-to-manage movement disorders due to malfunctioning of pathological circuits in the brain.